FDA.reportPublic FDA data

7 ML amivantamab-vmjw 50 MG/ML Injection

RxCUI
2549734
RxNorm name
7 ML amivantamab-vmjw 50 MG/ML Injection
Display name
7 ML amivantamab-vmjw 50 MG/ML Injection
Full name
7 ML amivantamab-vmjw 50 MG/ML Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761210Rybrevantamivantamab-vmjw351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RybrevantAMIVANTAMAB-VMJWJanssen Biotech, Inc.1466c070-9f97-4fa4-a955-6a6b59981fb82025-11-11Warnings, Adverse reactionsExact identifier
rxcui: 2549734

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
1466c070-9f97-4fa4-a955-6a6b59981fb87 ML amivantamab-vmjw 50 MG/ML InjectionSCD16These highlights do not include all the information needed to use RYBREVANT safely and effectively. See full prescribing information for RYBREVANT. RYBREVANT ® (amivantamab-vmjw) injection, for intravenous use Initial U.S. Approval: 202120251111
1466c070-9f97-4fa4-a955-6a6b59981fb8amivantamab-vmjw 350 MG per 7 ML InjectionSY16These highlights do not include all the information needed to use RYBREVANT safely and effectively. See full prescribing information for RYBREVANT. RYBREVANT ® (amivantamab-vmjw) injection, for intravenous use Initial U.S. Approval: 202120251111
1466c070-9f97-4fa4-a955-6a6b59981fb8amivantamab-vmjw 50 MG/ML per 7 ML InjectionSY16These highlights do not include all the information needed to use RYBREVANT safely and effectively. See full prescribing information for RYBREVANT. RYBREVANT ® (amivantamab-vmjw) injection, for intravenous use Initial U.S. Approval: 202120251111
1466c070-9f97-4fa4-a955-6a6b59981fb8amivantamab-vmjw 350 MG in 7 ML InjectionPSN16These highlights do not include all the information needed to use RYBREVANT safely and effectively. See full prescribing information for RYBREVANT. RYBREVANT ® (amivantamab-vmjw) injection, for intravenous use Initial U.S. Approval: 202120251111